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bstract
Background. Percutaneous drainage of pyogenic liver abscess has become first-line treatment. In the past surgical drainage was preferred
n some centres.
Aim. The aim of this retrospective study was to assess the effectiveness of percutaneous treatments and surgical drainage, in terms of
reatment success, hospital stay and costs.
Patients. Data of 148 patients (90 males; 58 females; mean age, 61 yrs; range, 30–86 yrs) were retrospectively analysed.
Methods. Patients’ outcomes, including the length of hospital stay, procedure-related complications, treatment failure and death, were
ecorded. Multiple logistic regression model was used for statistical analysis.
Results. One hundred and four patients (83 with solitary and 21 with multiple abscesses) were treated percutaneously, either by needle
spiration (91 patients) or catheter drainage (13 patients) depending on the abscess’s size, and 44 patients (30 with solitary and 14 with multiple
bscesses) were treated surgically. There was no statistically significant difference in patients’ demographics or abscess characteristics between
roups. Hospital stay was longer, and costs were higher in patients treated surgically (p < 0.001). There was statistically significant differenceUN
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n morbidity rate between groups (p < 0.001). No death occurred in both groups.
Conclusions. Percutaneous and surgical treatment of pyogenic liver abscesses are both effective, nevertheless percutaneous drainage carries
ower morbidity and is cheaper.
2008 Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.
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. Introduction
Pyogenic liver abscess (PLA) is a serious, life threatening
ondition, with a mortality rate of 6–14% [1,2]. In the antibi-
tics era the most common predisposing factor has become
iliary tract disease that accounts for about 40% of cases, with
∗ Corresponding author. Tel.: +39 0382 502799; fax: +39 0382 301987.
E-mail address: ferraiol@tin.it (G. Ferraioli).
1 Present address: General Surgery Division, Lodi Hospital, Lodi (MI),
taly.
aetiological agents commonly represented by Gram-negative 35
and anaerobic bacteria [3,4]. 36
Other facilitating conditions are systemic infections 37
through haematogenous dissemination, penetrating traumas, 38
and abdominal surgical procedures in particular in patients 39
with impaired immunity due to malignancies, AIDS, dia- 40
betes, etc. [2,3,5,6]. 41
Therapeutic options are medical therapy alone, reserved 42
to few cases of multiple small pus collections [6,7], and 43
percutaneous or surgical drainage both in combination 44
with appropriate intravenous antibiotics. Over the last two 45
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decades, percutaneous drainage has become the first-line46
treatment in most cases [1,8–12], even though surgical47
drainage is more likely to be required in patients with48
abscess rupture, incomplete percutaneous drainage or who49
have uncorrected primary pathology [7].50
In the past surgical drainage was preferred in some centres51
[13]. A recent study has shown that for liver abscesses larger52
than 5 cm surgical drainage provides better clinical outcomes53
than percutaneous drainage with comparable morbidity and54
mortality rates [14].55
The aims of this study were to retrospectively analyse the56
clinical course of patients with PLA treated with percuta-57
neous or surgical drainage in a different period of time and to58
assess the effectiveness of both treatments in terms of success,59
number of secondary procedures, hospital stay, morbidity and60
mortality. In addition, comparison between the two groups61
was made and the benefits of both procedures in relation to62
their costs were retrospectively analysed.63
2. Patients and methods64
2.1. Patients65
Data of patients admitted to two Departments of Infectious66
Diseases at two different institutions, San Matteo Hospital in67
Pavia and Cotugno Hospital in Naples, from January 199868
to December 2002 were retrospectively collected. Besides,69
data of patients admitted to the Department of Surgery at San70
Matteo Hospital in Pavia from November 1981 to December71
2002 were also collected. The medical files of 163 patients72
affected by PLA treated either percutaneously or surgically73
were retrieved. Amoebic abscesses and hydatid liver cysts74
were actively excluded. Fifteen patients with PLA were75
excluded from the analysis because some data were miss-76
ing.77
Thus, our study cohort consisted of 148 patients (90 males;78
58 females; mean age, 61 yrs; range, 30–86 yrs). In partic-79
ular, 79 patients (47 males; 32 females; mean age, 62 yrs;80
range, 39–86 yrs) were treated at the Department of Infec-81
tious Diseases of Cotugno Hospital, 25 patients (16 males; 982
females; mean age, 63 yrs; range, 30–80 yrs) at the Depart-83
ment of Infectious Diseases of San Matteo Hospital, and 4484
patients (27 males; 17 females; mean age, 57 yrs; range,85
32–82 yrs) at the Department of Surgery of San Matteo Hos-86
pital.87
The diagnosis of PLA was made by ultrasonography (US)88
alone in 118 patients, by US and computed tomography in89
25 patients, by computed tomography alone in four patients,90
and by magnetic resonance imaging alone in one patient.91
All 104 patients (63 males; 41 females; mean age, 63 yrs;92
range, 30–86 yrs) from the two Departments of Infectious93
Diseases were treated percutaneously (PT), either by fine-94
needle aspiration (NA) or catheter drainage (CD), depending95
on abscesses size. The 44 patients from the Department of96
Surgery of San Matteo Hospital were treated surgically (ST).
2.2. Methods 97
This retrospective study was approved by the institutional 98
ethics review board of both hospitals that waived the require- 99
ment for informed consent. 100
Underlying pathologies, size and number of the abscesses 101
were determined. In case of multiple abscesses, the size of 102
the largest one was estimated. 103
Patients’ outcomes, including the length of hospital stay, 104
procedure-related complications, treatment failure and death, 105
were recorded. 106
2.2.1. Percutaneous treatments 107
Both NA and CD were performed under US guidance. 108
The US systems used during the study period were Aloka 109
Prosound SSD-5000 (Tokyo, Japan) with a 3.0–6.0 MHz con- 110
vex array broadband probe and a 3.5 MHz microconvex probe 111
at the Department of Infectious Diseases of Cotugno Hospi- 112
tal, and AU5 Harmonic (ESAOTE, Genoa, Italy) equipped 113
with a 3.5–5.0 MHz convex array probe at Department of 114
Infectious Diseases of San Matteo Hospital. 115
The freehand technique was used both at Cotugno Hospital 116
and at San Matteo Hospital. 117
On both institutions the methodologies for percutaneous 118
needle aspiration and catheter drainage elsewhere described 119
were followed [6,15]. 120
As a rule, fine-needle aspiration was used for abscesses 121
up to 6 cm in size. Catheter from 8 to 10 F was positioned 122
in case of abscesses larger than 6 cm, and removed when no 123
more than 10–20 mL of material was drained during a period 124
of 24 h. 125
2.2.2. Surgical treatment 126
Surgical drainage was performed as the first-line treatment 127
due to the choice of the surgical team until the year 2000, 128
afterwards there was a case discussion with the team of infec- 129
tious diseases units. In case of failure of surgical drainage, 130
hepatic resection was executed. 131
Either in patients treated percutaneously or surgically, 132
aerobic, anaerobic and fungal cultures were performed on 133
the aspirated material, accompanied by sensitivity testing. 134
Systemic broad-spectrum antibiotics were administered until 135
the results of pus culture were available. Afterwards, the 136
most active antibiotic was given. In patients with a cyto- 137
logical diagnosis of abscess but negative findings of pus 138
cultures, broad-spectrum antibiotic therapy was continued. 139
The patients were discharged from the hospital on oral 140
antibiotics, to complete a 6-week course from the time of 141
procedure, when fever and clinical signs disappeared and the 142
abscess’ dimensions were reduced to at least one-third of the 143
initial size on US examination. 144
2.3. Variables 145
We considered sex, age, number and size of abscess, 146
relapses and length of hospital stay. Besides, based on 147
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duration of hospital stay and therapeutic procedures, we cal-148
culated costs.149
2.4. Costs150
The costs were calculated using diagnosis related group151
(DRG) system, a method currently used in the USA and152
in some European countries to reimburse hospitals. The153
DRG system classifies hospital cases into approximately154
500 groups, each one expected to consume similar hospi-155
tal resource. The effective reimbursement is fixed for groups156
of pathology, related to a chosen treatment, and increases in157
case of complications. In the DRG system the hospitalization158
length is established according to procedures used.159
In the reimbursement scheme adopted in our country,160
there is no difference between hepatic resection and surgi-161
cal drainage. Thus, costs are unaffected by different surgical162
procedures.163
2.5. Follow-up164
The follow-up was based on US and clinical examina-165
tions performed in all patients every 3 days during the first166
week, monthly for the first 6 months after the procedure, and167
every 6 months thereafter. Follow-up studies were terminated168
when findings of two consecutive US examinations showed169
complete healing of the liver parenchyma.170
2.6. Statistical analysis171
Continuous variables were summarized as frequency and172
percentage. Multiple logistic regression model was used to173
assess the relationship between length of hospitalization and174
demographic and clinical characteristics of the patients. In175
the model the dependent variable was length of hospital stay176
coded as 0 when shorter or equal to 14 days (short hospitaliza-177
tion) or as 1 when longer than 14 days (long hospitalization).178
As candidate risk factors for longer hospitalization we con-179
sidered age, sex, abscess number, size, and percutaneous or180
surgical treatment.181
Variables found to be associated to the dependent variables182
on univariate logistic regression at a probability threshold183
<0.10 were included in multivariate logistic regression mod-184
els.185
Regression analysis was performed using PROC LOGIS-186
TIC sub routine in SAS (SAS Institute, Inc. Cary, North187
Carolina, USA). A p value less than 0.05 was considered188
to indicate a statistically significant difference.189
3. Results190
Two hundred and five PLA were found in 148 patients.191
The results of pus cultures are reported in Table 1.192
Thirty-five of 148 patients (23.6%) had multiple liver193
abscesses (range 2–8).194
Table 1
Results of pus cultures in 148 patients with 205 pyogenic liver abscesses
Results of pus culture PT ST Overall
Aerobic organism
Escherichia coli 24 (23.1) 13 (29.5) 37 (25.0)
Staphylococcus aureus 8 (7.7) 4 (9.1) 12 (8.1)
Klebsiella 8 (7.7) 2 (4.6) 10 (6.8)
Enterobacter – 1 (2.3) 1 (0.7)
Anaerobic organism
Peptostreptococcus spp. 10 (9.6) 4 (9.1) 14 (9.4)
Bacteroides 8 (7.7) – 8 (5.4)
Fusobacterium 2 (1.9) – 2 (1.4)
Others 9 (8.7) 3 (6.8) 12 (8.1)
Mixed 12 (11.5) 4 (9.1) 16 (10.8)
Negative 23 (22.1) 13 (29.5) 36 (24.3)
Total 104 44 148
PT: percutaneously treated patients; ST: surgically treated patients. Figures
in parenthesis are percentages.
Table 2
Underlying pathology of the 148 patients with 205 pyogenic liver abscesses
Underlying pathology PT ST Overall
No. (%) No. (%) No. (%)
Biliary tract diseases 17 (16.3) 12 (27.3) 29 (19.6)
Acute cholecystitis 5 (4.8) 4 (9.1) 9 (6.1)
Ascending cholangitis 12 (11.5) 8 (18.2) 20 (13.5)
Malignancies 36 (34.6) 16 (36.4) 52 (35.1)
AIDS 8 (7.7) – 8 (5.4)
Diabetes 9 (8.7) 6 (13.6) 15 (10.1)
Previous abdominal surgery 9 (8.7) – 9 (6.1)
Others 22 (21.1) 9 (20.4) 31 (21.0)
Cryptogenic 3 (2.9) 1 (2.3) 4 (2.7)
Total 104 44 148
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The mean size of the abscesses was 5.2 cm (range
.7–12.0 cm).
Underlying pathologies of abscess formation are reported
n Table 2. A potential underlying pathology was found in 144
f 148 patients (97.3%). In 21 of 52 patients (40.4%) with
alignancies, the primary site was the biliary tract. Eleven
f 29 patients (37.9%) with biliary diseases had had a prior
iliary procedure.urgical treatment of pyogenic liver abscesses: Observation over a
008.01.016
Patients’ clinical characteristics on admission are reported 203
n Table 3. No septic condition was recorded in our cohorts. 204
able 3
linical characteristics on admission in the 148 patients with 205 pyogenic
iver abscesses
ymptoms and signs No. of patients (%)
ever 133 (89.9)
ausea 101 (68.2)
bdominal pain 59 (39.9)
aundice 30 (20.3)
epatomegaly 77 (52.0)
igures in parenthesis are percentages.
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Table 4
Variable analysed in the 148 patients with 205 pyogenic liver abscesses
Variable All PT (%) ST (%) Statistical significance
Patients no. 148 104 44
Mean age (yr) 61 63 57 ns
Sex
Male 90 (60.8) 63 (60.5) 27 (61.3) ns
Female 58 (39.2) 41 (39.5) 17 (38.7) ns
Patients with solitary abscess 113 (76.4) 83 (79.8) 30 (68.2)
Patients with multiple abscesses 35 (23.6) 21 (20.2) 14 (31.8)
Abscess mean size (cm) 5.2 5.1 5.3 ns
Hospital stay in days (range)
All patients 10.5 (3–38) 5.7 (3–18) 19.0 (6–38) 0.001
Patients with solitary abscess 9.8 (3–38) 5.6 (3–10) 19.2 (6–38) 0.001
Patients with multiple abscesses 13.2 (3–31) 6.
PT: percutaneously treated patients; ST: surgically treated patients. Figures in paren
3.1. Percutaneous treatments group205
A hundred and four patients with 138 PLA were treated206
percutaneously. Eighty-three of 104 patients (79.8%) had207
solitary and 21 of 104 patients (20.2%) multiple PLAs. The208
mean diameter of PLA was 5.1 cm (range, 1.7–12.0 cm)209
(Table 4).210
No statistically significant difference was found between211
patients from the two different departments of infectious212
diseases in terms of clinical data and abscess characteris-213
tics.214
The length of hospital stay ranged from 3 to 10 days (mean,215
5.6 days) for patients with solitary PLA, and from 3 to 18216
days (mean, 6.7 days) for patients with multiple PLA, the217
difference did not reach statistical significance. A hundred218
and three of 104 patients (99.0%) had a hospital stay duration219
of less than 14 days.220
No death occurred. No procedure-related complications221
occurred.222
Ninety-one of 104 patients (87.5%) were treated by NA,223
and 13 of 104 patients (12.5%) by CD. Abscesses treated224
with CD were larger than those treated with NA (mean size,225
8.0 cm; range 5.5–12.0 cm; versus mean size, 4.3 cm; range,226
1.7–8.0 cm).227
Eighty-five of 91 (93.4%) patients were treated in a sin-228
gle session. In 66 of 85 (77.6%) a single needle insertion229
was performed, whereas in 19 of 85 (22.4%) more than one230
needle insertion was required. In 6/91 (6.6%) patients, two231
sessions of NA were necessary because the fever did not232
remit, and the size of PLAs remained unchanged on US233
examination.234
All percutaneous treatments were successful. None235
required surgery.236
3.2. Surgical treatment group237
Forty-four patients with 67 PLA were treated surgically.238
Thirty of 44 patients (68.2%) had solitary and 14 of 44239
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O7 (3–18) 18.7 (11–31) 0.001thesis are percentages. Statistical significance: PT versus ST.
atients (31.8%) had multiple PLAs. The mean diameter was
.3 cm (range, 2.0–12.0 cm) (Table 4). Length of hospital stay
anged from 6 to 38 days (mean, 19.2 days) for patients with
olitary PLA, and from 11 to 31 days (mean, 18.7 days) for
atients with multiple PLA, without a statistically significant
ifference. Eleven of 44 patients (25.0%) had a hospital stay
f less than 14 days.
No death occurred. The overall morbidity rate was 9.1%.
wo patients experienced pneumonia, one pleural effusion
equiring drainage, and one wound infection.
Surgical drainage was successful in 41of 44 patients
93.2%), but three of 41 patients (7.3%) required a second
atheter insertion because of incomplete drainage. Three of
4 patients (6.8%) had hepatic resection because of sur-
ical drainage failure. Two of them had single PLA and
ne multiple PLA. In these three patients, the abscesses
ize did not decrease and fever persisted despite antibi-
tics. They all had multiloculated abscesses containing thick
aterial.
.3. Costs
The PT costs per patient were Euro 1746.88 in case of
ncomplicated PLA and Euro 3105.44 for the complicatedurgical treatment of pyogenic liver abscesses: Observation over a
008.01.016
ne. The calculated reimbursement is the same for a hospital 262
tay of 3–29 days. In our series of patients, no complications 263
ere recorded. Thus, the mean cost per patient was Euro 264
746.88. 265
able 5
RG reimbursement scheme for liver abscesses
rocedure DRG reimbursement (in Euro)
Uncomplicated
abscess
Complicated
abscess
ercutaneous treatment 1,746.88 3,105.44
urgical drainage 5,287.99 17,101.00
urgical resection 5,287.99 17,101.00
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The costs of hepatic resection or surgical drainage with266
incision were Euro 5287.99 for uncomplicated cases, and267
Euro 17,101.00 for complicated cases. The mean cost per268
patient was Euro 6898.85 (Table 5).269
3.4. Comparison between percutaneous treatment270
(n = 104) and surgical treatment (n = 44) groups271
There was no statistically significant difference in272
patients’ demographics of the two groups. AIDS was an273
underlying disease only in the PT group, whereas biliary274
tract diseases were more common in the ST group (27.3%275
versus 16.3%). Only patients in the PT group had previ-276
ous abdominal surgery. No statistical difference in abscess277
size was observed. Multiple PLAs were found in 31.8% of278
cases in ST group and 20.2% in the PT group (p < 0.05)279
(Table 4). Within groups, there was no statistically signif-280
icant difference in length of hospital stay between patients281
with solitary and with multiple PLA. There were three282
treatment failures in the ST group, and none in the PT283
group.284
There was a statistically significant difference in the mor-285
bidity rate between the two groups (p < 0.001). Costs of PT286
were significantly lower than costs of ST (p < 0.001).287
From the multivariate analysis, surgical therapy was the288
only predictor of long hospitalization (>14 days).289
3.5. Follow-up290
Complete resolution of parenchymal lesions at imaging291
was observed within maximum 86 days (range, 44–86 days;292
mean, 56 days) after discharge from the hospital. During293
the follow-up, (range, 4–12 months; mean, 9 months) no294
recurrence of abscesses was observed in both groups. No295
differences were observed between the two groups in terms296
of time to healing.297
Eight patients were lost to follow-up before complete heal-298
ing of liver abscess was achieved.299
4. Discussion300
In the last decades, the treatment and prognosis of301
pyogenic liver abscesses have significantly improved [16].302
The use of new antimicrobials, advancements in diagnos-303
tic imaging techniques, and percutaneous image-guided304
drainage procedures are the main factors accounting for the305
observed improvements [1,9,11,16,17]. Nowadays, image-306
guided percutaneous drainage is the treatment of choice307
of PLA. It must be available in every hepato-biliary unit308
where a close cooperation between surgeons and inter-309
ventional radiologists usually exists. The presence of a310
coexisting primary intra-abdominal pathology, the success311
rate of the procedure and expertise in managing PLA312
are factors to be considered in selecting the choice of313
therapy [1]. Surgery is reserved to severe cases, such as314
operative treatment of causative underlying diseases. Thus, 315
percutaneous and surgical techniques are not competing 316
methods, but have different indications and surgery also 317
represents an option for non-responders to percutaneous 318
treatment. 319
In this retrospective study, the results obtained in the 320
two groups are not completely comparable because they 321
were observed in different period of time. Nonetheless, 322
they show that, independently from the management strat- 323
egy used for PLA treatment, all patients recovered. The 324
patients in the ST group had a significantly longer dura- 325
tion of hospital stay. Even though the rate of multiple PLAs 326
was significantly higher in the ST group compared to the 327
PT group the abscesses number did not significantly affect 328
the length of hospital stay. Patients with multiple PLA 329
had a shorter hospitalization in the PT group compared to 330
ST group. The effectiveness of percutaneous drainage of 331
multiple PLA was similar to that of surgery. This result 332
is in keeping with other published studies [18,19], and 333
suggest that percutaneous drainage should always be under- 334
taken before surgery, the latter being reserved to selected 335
cases such as those in which the percutaneous option has 336
failed or with large multiloculated abscesses containing 337
thick pus or when an underlying pathology requires oper- 338
ation. In our study, none patients in the PT group had 339
underlying pathologies needing a not deferrable surgical 340
treatment. 341
There are dissimilarities in patients’ population between 342
our series and that of other studies [2,3,5]. In our series, 343
malignancy was the most frequent underlying pathology in 344
both groups. Moreover, 8 of 104 patients (7.7%) in the PT 345
group had AIDS. Both conditions might be associated with 346
a poor prognosis [6,16]. Nonetheless, no death occurred dur- 347
ing the hospitalization and the follow-up period. Besides, 348
in our series of patients there were nine cases of postsurgi- 349
cal PLA in the PT group. These differences in underlying 350
pathologies did not lead to a longer duration of hospital stay 351
compared to literature data [1,18]. In our series the mean 352
follow up period was 9 months and it was tailored to liver 353
abscess healing and not to underlying pathologies. It was 354
terminated when findings of two consecutive US exami- 355
nations showed complete healing of the liver parenchyma. 356
Eight patients were lost to follow up before complete heal- 357
ing of liver abscess was achieved. Taking this into account 358
makes our results less surprising and more in keeping with 359
the available literature. Gram-negative aerobes were the 360
major abscess pathogens in our series. Similar to other 361
reports [3,13,18], Escherichia coli was the most common 362
pathogen, with a percentage of 25% of cases. The spectrum 363
of causative organisms is similar to other European stud- 364
ies, but in Asian countries other distributions are seen (with 365
high proportions of Klebsiella) [20]. The comparability with 366
these patients’ population is therefore limited. In 24.3% of 367
cases, the results of pus culture were negative. This find- 368
ing might be due to antimicrobial therapy regimen before 369
hospitalization. 370
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No significant difference was found between the PT and371
ST group in terms of treatment success rate, suggesting that372
both procedure are effective.373
Nonetheless, the aggressiveness of surgery should be374
taken into account. Patients in the ST showed a longer length375
of hospital stay and a higher morbidity rate.376
This being a retrospective study, the selection criteria377
were also a function of time period considered; specifi-378
cally, PTs were chosen where and when available (i.e. in379
the two departments of infectious diseases they were con-380
sidered first choice based on the available local expertise)381
whereas surgical drainage was chosen by local surgeons as382
a first-line treatment, based on their own expertise and the383
time of intervention. This was 1981–2002, which includes a384
decade when PTs were not as popular as they became later385
on.386
Over the last two decades, open surgical drainage has been387
increasingly been reserved to patients unsuitable for percu-388
taneous drainage, the latter being safe, less invasive, more389
acceptable to patients and cheaper.390
Nowadays, besides effectiveness of a treatment and reduc-391
tion of patient discomfort, procedure-related costs is another392
issue that should be taken into account. Yet, to our knowl-393
edge, an analysis of costs of PT and ST has never been394
attempted. In a world of limited health care resources, the395
benefits of an intervention in relation to its costs should be396
considered, in order to balance costs against clinical out-397
comes. Economic evaluations are increasingly common in398
the medical literature [21–23]. Assigning a monetary value399
to a service or consumed resource is not trivial because clin-400
icians should be aware not only of the clinical benefits of401
a particular strategy, but of the economic consequences as402
well.403
All but one patient in the PT group had a hospitalization404
shorter than 14 days and the statistical analysis showed that405
the only factor influencing length of hospitalization was the406
type of treatment (ST or PT).407
There are a number of limitations to our study. First, it408
was retrospective and the analysis of costs could only be409
based on DRGs. Second, costs presented in this study were410
not adjusted to the medical care costs of the study period.411
We did not think that this adjustment was necessary because412
changes in costs would have the same effect on both proce-413
dures.414
Third, the number of patients in the surgically treated415
series is different from that of the percutaneously treated416
series. This is because percutaneous drainage has become417
the preferred choice of PLA treatment in the last418
decade.419
The results of this study confirm that percutaneous and420
surgical treatment of pyogenic liver abscesses are both effec-421
tive, but percutaneous drainage carries lower morbidity and is422
cheaper. In similar clinical settings, percutaneous drainage of423
liver abscesses should always be attempted as the first choice424
treatment, and it might help to optimise clinical conditions425
prior to surgery.
Practice points
• In our seriesGram-negative aerobeswere the
major abscess pathogens. Escherichia coli
was the most common pathogen, with a per-
centage of 25% of cases.
• The results of our study suggest that percuta-
neous drainage should always be undertaken
before surgery, the latter being reserved
to selected cases such as those in which
the percutaneous option has failed or with
large multiloculated abscesses containing
thick pus or when an underlying surgical
pathology requires operation.
• Percutaneous drainage must be available in
every hepato-biliary unit where a close coop-
eration between surgeons and interventional
radiologists usually exists.
Research agenda
• Percutaneous drainage of liver abscesses
should always be attempted as the ﬁrst
choice treatment, and it might help to opti-
mise clinical conditions prior to surgery.
• Prospective studies on comparative analysis
of procedure-related costs are needed.
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